Carlyle Group Inc.
CIK: 0001527166Latest portfolio: $13.6B · Q4 2025
Holdings
20
Total Value
$13.6B
New Positions
4
Closed Positions
1
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | MDLNMedline Inc | 215,303,036 | $9.0B | 66.65% | NEW | |
| 2 | SAROStandardaero Inc | 152,673,891 | $4.4B | 32.27% | — | |
| 3 | PHATPhathom Pharmaceuticals Inc | 3,496,808 | $58.0M | 0.43% | — | |
| 4 | PONYPony Ai Inc | 2,362,447 | $34.3M | 0.25% | — | |
| 5 | INVHInvitation Homes Inc | 664,100 | $18.5M | 0.14% | +187K | |
| 6 | GETYGetty Images Holdings Inc | 6,234,252 | $8.4M | 0.06% | — | |
| 7 | CUBECubeSmart | 220,500 | $7.9M | 0.06% | — | |
| 8 | QTTBQ32 Bio Inc | 1,102,741 | $3.6M | 0.03% | — | |
| 9 | SPRBSpruce Biosciences Inc | 38,620 | $3.3M | 0.02% | -2,857,898 | |
| 10 | FWRDForward Air Corp | 107,214 | $3.1M | 0.02% | — | |
| 11 | JSPRJasper Therapeutics Inc | 1,066,189 | $1.9M | 0.01% | — | |
| 12 | ACETAdicet Bio Inc | 184,295 | $1.5M | 0.01% | NEW | |
| 13 | DNUTKrispy Kreme Inc | 340,748 | $1.4M | 0.01% | — | |
| 14 | OKUROnkure Therapeutics Inc | 269,895 | $771K | 0.01% | — | |
| 15 | NABLN-able Inc | 93,732 | $701K | 0.01% | — | |
| 16 | SPWRSunPower Inc | 433,158 | $680K | 0.01% | -825,812 | |
| 17 | NCNANucana Plc | 133,333 | $479K | 0.00% | — | |
| 18 | HOODRobinhood Mkts Inc | 3,376 | $381K | 0.00% | NEW | |
| 19 | SYRESpyre Therapeutics Inc | 9,620 | $315K | 0.00% | NEW | |
| 20 | XCURExicure Inc | 56,328 | $304K | 0.00% | -225,308 |
Quarterly Changes
Sector Breakdown
Healthcare0.0% ($9.042727579773616e+30T)
Industrials0.0% ($4378687.3T)
Real Estate0.0% ($184.6B)
Communication Services0.0% ($8.4M)
Consumer Defensive0.0% ($1.4M)
Technology0.0% ($701K)
Energy0.0% ($680K)
Financial Services0.0% ($381K)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 13, 2026 | $13.6B | 20 |
| Q3 2025 | Nov 7, 2025 | $4.3T | 17 |
| Q2 2025 | Aug 8, 2025 | $5.0T | 20 |
| Q1 2025 | May 9, 2025 | $3.8T | 23 |
| Q4 2024 | Feb 13, 2025 | $4.1T | 27 |
| Q3 2024 | Nov 8, 2024 | $954.2T | 26 |
| Q2 2024 | Aug 9, 2024 | $1053.0T | 31 |
| Q1 2024 | May 3, 2024 | $1586.3T | 32 |
| Q4 2023 | Feb 2, 2024 | $2079.2T | 25 |
| Q3 2023 | Nov 3, 2023 | $2305.6T | 26 |
| Q2 2023 | Aug 4, 2023 | $2807.3T | 27 |
| Q1 2023 | May 5, 2023 | $3352.2T | 31 |
| Q4 2022 | Feb 10, 2023 | $3437.0T | 14 |
| Q3 2022 | Nov 10, 2022 | $3.1T | 12 |
| Q2 2022 | Aug 12, 2022 | $5.8T | 10 |
| Q1 2022 | May 13, 2022 | $8.4T | 8 |
| Q4 2021 | Feb 11, 2022 | $9.6T | 9 |
| Q3 2021 | Nov 12, 2021 | $12.6T | 11 |
| Q2 2021 | Aug 12, 2021 | $14.8T | 11 |
| Q1 2021 | May 14, 2021 | $13.2T | 13 |
| Q4 2020 | Feb 12, 2021 | $7.5T | 10 |
| Q3 2020 | Nov 13, 2020 | $7.3T | 11 |
| Q2 2020 | Aug 13, 2020 | $8.8T | 14 |
| Q1 2020 | May 13, 2020 | $2.4T | 14 |
| Q4 2019 | Feb 13, 2020 | $1.5T | 12 |
| Q3 2019 | Nov 13, 2019 | $1.6T | 12 |
| Q2 2019 | Aug 13, 2019 | $2.0T | 11 |
| Q1 2019 | May 13, 2019 | $2.1T | 11 |
| Q4 2018 | Feb 14, 2019 | $1.4T | 10 |
| Q3 2018 | Nov 13, 2018 | $2.0T | 10 |
| Q2 2018 | Aug 14, 2018 | $2.2T | 11 |
| Q1 2018 | May 14, 2018 | $2.4T | 12 |
| Q4 2017 | Feb 14, 2018 | $1.5T | 11 |
| Q3 2017 | Nov 13, 2017 | $1.6T | 14 |
| Q2 2017 | Aug 11, 2017 | $1.5T | 15 |
| Q1 2017 | May 11, 2017 | $2.1T | 15 |
| Q4 2016 | Feb 10, 2017 | $2.4T | 16 |
| Q3 2016 | Nov 14, 2016 | $3.8T | 19 |
| Q2 2016 | Aug 10, 2016 | $5.7T | 28 |
| Q1 2016 | May 13, 2016 | $8.0T | 31 |
Fund Information
Carlyle Group Inc. is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $13.6B across 20 holdings. The largest position is Medline Inc (MDLN), representing 66.7% of the portfolio. Compared to the previous quarter, the fund opened 4 new positions and closed 1 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.